JAMES D CAREY
Plumbing Contractor at Redmont, Cincinnati, OH
License number
Ohio PL.32532
Effective Date
Jan 1, 2017
Expiration Date
Dec 31, 2017
Type
Plumbing Contractors
Address
Address
4340 Redmont Ave, Cincinnati, OH 45236
Phone
(513) 984-2792
Organization information
See more information about JAMES D CAREY at bizstanding.comCarey Plumbing Inc
4340 Redmont Ave, Cincinnati, OH 45236
Status:
Inactive
Industry:
Plumbing/Heating/Air Cond Contractor
Phone:
(513) 984-2792 (Phone)
Categories:
Plumbing Contractors
Professional information
James Paul Carey, Cincinnati OH - Lawyer
Address:
Wood, Herron & Evans, LLP
2700 Vine St, Cincinnati 45202
(513) 241-2324
2700 Vine St, Cincinnati 45202
(513) 241-2324
Licenses:
Ohio - Active 2008
Education:
University of Dayton
Heterocyclic Substituted Carbonyl Derivatives And Their Use As Dopamine Dreceptor Ligands
US Patent:
7186724, Mar 6, 2007
Filed:
Apr 6, 2004
Appl. No.:
10/819037
Inventors:
James A Hendrix - Hillsborough NJ, US
Horst Hemmerle - Bad Soden, DE
Matthias Urmann - Eschborn DE, US
Gregory M Shutske - Pittstown NJ, US
Jospeh T Strupczewski - Flemington NJ, US
Kenneth J Bordeau - Kintnersville PA, US
John G Jurcak - Bethlehem PA, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon A Jackson - Whitehouse Station NJ, US
Paul Angell - Liberty Township OH, US
James P Carey - Cincinnati OH, US
George Lee - Somerville NJ, US
David Fink - Lebanon NJ, US
Jean-Fancois Sabuco - Paris, FR
Yulin Chiang - Convent Station NJ, US
Nicola Collar - Madison NJ, US
Horst Hemmerle - Bad Soden, DE
Matthias Urmann - Eschborn DE, US
Gregory M Shutske - Pittstown NJ, US
Jospeh T Strupczewski - Flemington NJ, US
Kenneth J Bordeau - Kintnersville PA, US
John G Jurcak - Bethlehem PA, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon A Jackson - Whitehouse Station NJ, US
Paul Angell - Liberty Township OH, US
James P Carey - Cincinnati OH, US
George Lee - Somerville NJ, US
David Fink - Lebanon NJ, US
Jean-Fancois Sabuco - Paris, FR
Yulin Chiang - Convent Station NJ, US
Nicola Collar - Madison NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 31/496, C07D 409/04, C07D 409/14, A61K 31/4535, A61K 31/454, C07D 403/04
US Classification:
51425213, 51425404, 51425406, 51425409, 544368, 544370, 544371, 544373, 544376, 544121, 544360, 544361, 544362, 544131, 544295, 546187, 546193, 546194, 546198
Abstract:
The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine Dreceptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine Dreceptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e. g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine Dreceptors.
Heterocyclic Substituted Carbonyl Derivatives And Their Use As Dopamine Dreceptor Ligands
US Patent:
7772252, Aug 10, 2010
Filed:
Apr 17, 2009
Appl. No.:
12/425731
Inventors:
James Hendrix - Hillsborough NJ, US
Horst Hemmerle - Noblesville IN, US
Matthias Urmann - Eschborn, DE
Gregory M Shutske - Pittstown NJ, US
Joseph T Strupczewski - Flemington NJ, US
Kenneth J Bordeau - Kintersville PA, US
John G Jurcak - Bethlehem PA, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon A. Jackson - Whitehouse Station NJ, US
Paul Angell - Middletown OH, US
James P Carey - Cincinnati OH, US
George Lee - Somerville NJ, US
David Fink - Lebanon NJ, US
Jean-Francois Sabuco - Paris, FR
Yulin Chiang - Convent Station NJ, US
Nicola Collar - Hoboken NJ, US
Horst Hemmerle - Noblesville IN, US
Matthias Urmann - Eschborn, DE
Gregory M Shutske - Pittstown NJ, US
Joseph T Strupczewski - Flemington NJ, US
Kenneth J Bordeau - Kintersville PA, US
John G Jurcak - Bethlehem PA, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon A. Jackson - Whitehouse Station NJ, US
Paul Angell - Middletown OH, US
James P Carey - Cincinnati OH, US
George Lee - Somerville NJ, US
David Fink - Lebanon NJ, US
Jean-Francois Sabuco - Paris, FR
Yulin Chiang - Convent Station NJ, US
Nicola Collar - Hoboken NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 31/4535, C07D 409/04, C07D 409/14, C07D 495/04
US Classification:
514316, 514321, 546187, 546198, 546202
Abstract:
The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine Dreceptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine Dreceptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e. g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine Dreceptors.
Heterocyclic Substituted Carbonyl Derivatives And Their Use As Dopamine D Receptor Ligands
US Patent:
7521445, Apr 21, 2009
Filed:
Mar 5, 2007
Appl. No.:
11/714047
Inventors:
James Hendrix - Hillsborough NJ, US
Horst Hemmerle - Noblesville IN, US
Matthias Urmann - Eschborn, DE
Gregory M Shutske - Pittstown NJ, US
Joseph T Strupczewski - Flemington NJ, US
Kenneth J Bordeau - Kintnersville PA, US
John G Jurcak - Bethlehem PA, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon A. Jackson - Whitehouse Station NJ, US
Paul Angell - Middletown OH, US
James P Carey - Cincinnati OH, US
George Lee - Somerville NJ, US
David Fink - Lebanon NJ, US
Jean-Francois Sabuco - Paris, FR
Yulin Chiang - Convent Station NJ, US
Nicola Collar - Hoboken NJ, US
Horst Hemmerle - Noblesville IN, US
Matthias Urmann - Eschborn, DE
Gregory M Shutske - Pittstown NJ, US
Joseph T Strupczewski - Flemington NJ, US
Kenneth J Bordeau - Kintnersville PA, US
John G Jurcak - Bethlehem PA, US
Thaddeus Nieduzak - Bridgewater NJ, US
Sharon A. Jackson - Whitehouse Station NJ, US
Paul Angell - Middletown OH, US
James P Carey - Cincinnati OH, US
George Lee - Somerville NJ, US
David Fink - Lebanon NJ, US
Jean-Francois Sabuco - Paris, FR
Yulin Chiang - Convent Station NJ, US
Nicola Collar - Hoboken NJ, US
Assignee:
Aventis Pharmaceuticals Inc. - Bridgewater NJ
International Classification:
A61K 31/5377, A61K 31/454, A61K 31/4535, A61K 31/4525, C07D 498/04, C07D 413/04, C07D 409/04
US Classification:
5142338, 5142345, 5142352, 514316, 514321, 514322, 514324, 544130, 546187, 546198, 546199, 546202
Abstract:
The invention relates to heterocyclic substituted carbonyl derivatives that display selective binding to dopamine Dreceptors. In another aspect, the invention relates to a method for treating central nervous system disorders associated with the dopamine Dreceptor activity in a patient in need of such treatment comprising administering to the subject a therapeutically effective amount of said compounds for alleviation of such disorder. The central nervous system disorders that may be treated with these compounds include Psychotic Disorders, Substance Dependence, Substance Abuse, Dyskinetic Disorders (e. g. Parkinson's Disease, Parkinsonism, Neuroleptic-Induced Tardive Dyskinesia, Gilles de la Tourette Syndrome and Huntington's Disease), Dementia, Anxiety Disorders, Sleep Disorders, Circadian Rhythm Disorders and Mood Disorders. The subject invention is also directed towards processes for the preparation of the compounds described herein as well as methods for making and using the compounds as imaging agents for dopamine Dreceptors.